The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Abbott Australasia Pty Ltd Diagnostic Division
Regulatory activities for this sponsor.
Loading...
Sponsor content
20 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Abbott Australasia Pty Ltd Diagnostic Division - Software IVDs.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Abbott Australasia Pty Ltd Diagnostic Division - Multiple clinical chemistry constituent IVDs.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Abbott Australasia Pty Ltd Diagnostic Division - Clinical chemistry enzyme IVDs.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Abbott Australasia Pty Ltd Diagnostic Division - Clinical chemistry substrate IVDs.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Abbott Australasia Pty Ltd Diagnostic Division - Clinical chemistry electrolyte IVDs.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Abbott Australasia Pty Ltd Diagnostic Division - Severe acute respiratory syndrome-associated coronavirus IVDs.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Abbott Australasia Pty Ltd Diagnostic Division - Troponin IVDs.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Abbott Australasia Pty Ltd Diagnostic Division - Software IVDs.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Abbott Australasia Pty Ltd Diagnostic Division - ARCHITECT HBsAg Next Confirmatory Assay - Hepatitis B virus surface antigen IVD, kit, chemiluminescent immunoassay.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Abbott Australasia Pty Ltd Diagnostic Division - ARCHITECT HBsAg Next Qualitative Assay - Hepatitis B virus surface antigen IVD, kit, chemiluminescent immunoassay.